Clinical outcomes of major clinical events and emergency triheptanoin use in critically ill patients with long-chain fatty acid oxidation disorders

被引：0
|
作者：
Enns, Gregory [1 ]
Marsden, Deborah [2 ]
Ramirez, Antonio Nino [2 ]
Bedrosian, Camille [2 ]
Reineking, Bridget [2 ]
Lu, Xiaoxiao [2 ]
Rahman, Syeda [2 ]
Vockley, Jerry [3 ]
机构：
[1] Stanford Univ, Stanford, CA 94305 USA
[2] Ultragenyx Pharmaceut Inc, Novato, CA USA
[3] Univ Pittsburgh, Pittsburgh, PA USA
来源：
MOLECULAR GENETICS AND METABOLISM | 2021年 / 132卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
eP130
引用
收藏
页码：S86 / S87
页数：3
相关论文
共 50 条
  • [21] Odd or even? Results from a randomized trial of triheptanoin compared to MCT in patients with long-chain fatty acid oxidation disorders
    Gillingham, Melanie B.
    Harding, Cary O.
    Vockley, Jerry
    MOLECULAR GENETICS AND METABOLISM, 2015, 114 (03) : 320 - 321
  • [22] Muscle MRI in patients with long-chain fatty acid oxidation disorders
    Diekman, Eugene F.
    van der Pol, W. Ludo
    Nievelstein, Rutger A. J.
    Houten, Sander M.
    Wijburg, Frits A.
    Visser, Gepke
    JOURNAL OF INHERITED METABOLIC DISEASE, 2014, 37 (03) : 405 - 413
  • [23] Mitochondrial fatty acid oxidation disorders: clinical presentation of long-chain fatty acid oxidation defects before and after newborn screening
    Spiekerkoetter, Ute
    JOURNAL OF INHERITED METABOLIC DISEASE, 2010, 33 (05) : 527 - 532
  • [24] Improvement in left ventricular ejection fraction in patients treated with triheptanoin for Long-chain Fatty Acid Oxidation Disorders (LC-FAOD)
    Ray, Kathryn
    Vockley, Jerry
    Ramirez, Antonio Nino
    Lu, Xiaoxiao
    Gillingham, Melanie
    GENETICS IN MEDICINE, 2022, 24 (03) : S101 - S101
  • [25] Triheptanoin treatment in patients with pediatric cardiomyopathy associated with long chain-fatty acid oxidation disorders
    Vockley, J.
    Charrow, J.
    Ganesh, J.
    Eswara, M.
    Diaz, G. A.
    McCracken, E.
    Conway, R.
    Enns, G. M.
    Starr, J.
    Wang, R.
    Abdenur, J. E.
    Sanchez-de-Toledo, J.
    Marsden, D. L.
    MOLECULAR GENETICS AND METABOLISM, 2016, 119 (03) : 223 - 231
  • [26] Impact of newborn screening on the reported incidence and clinical outcomes associated with medium- and long-chain fatty acid oxidation disorders
    Marsden, Deborah
    Bedrosian, Camille L.
    Vockley, Jerry
    GENETICS IN MEDICINE, 2021, 23 (05) : 816 - 829
  • [27] UNDERSTANDING THE BURDEN OF LONG-CHAIN FATTY ACID OXIDATION DISORDERS FOR PATIENTS AND CAREGIVERS
    Kruger, E.
    Voorhees, K.
    Thomas, N. A.
    Judge, M.
    Galla, J.
    Kung, J.
    Rodriguez, D.
    VALUE IN HEALTH, 2021, 24 : S205 - S205
  • [28] Understanding the impact of long-chain fatty acid oxidation disorders for patients and caregivers
    Kruger, Eliza
    Voorhees, Kristin
    Thomas, Nina
    Judge, Miller
    Galla, John
    Kung, Jeffrey
    Rodriguez, Diego
    MOLECULAR GENETICS AND METABOLISM REPORTS, 2022, 32
  • [29] Regulatory news: Dojolvi (triheptanoin) as a source of calories and fatty acids in long-chain fatty acid oxidation disorders: FDA approval summary
    Zand, Dina
    Doan, Jenny
    Yi, Sojeong
    Wang, Jie
    Ma, Lian
    Akinshola, Emmanuel
    Chakder, Sushanta
    Meyer, Joette
    Pacanowski, Michael
    Johnson, Laura Lee
    Donohue, Kathleen
    Beitz, Julie
    JOURNAL OF INHERITED METABOLIC DISEASE, 2021, 44 (03) : 515 - 517
  • [30] Long-term major clinical outcomes in patients with long chain fatty acid oxidation disorders before and after transition to triheptanoin treatment-A retrospective chart review (vol 116, pg 53, 2015)
    Vockley, Jerry
    Marsden, Deborah
    McCracken, Elizabeth
    DeWard, Stephanie
    Barone, Amanda
    Hsu, Kristen
    Kakkis, Emil
    MOLECULAR GENETICS AND METABOLISM, 2015, 116 (03) : 221 - 221
12345